Cutler Group LP Celldex Therapeutics, Inc. Call Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Jul 18, 2023	BUY	$30.29 - $38.28 $15,145 - $19,140	500 Added 500.0%	600 $1,000
Q1 2023 May 01, 2023	SELL	$34.78 - $47.43 $73,038 - $99,603	-2,100 Reduced 95.45%	100 $0
Q3 2022 Oct 25, 2022	SELL	$22.7 - $37.57 $814,930 - $1.35 Million	-35,900 Reduced 94.23%	2,200 $0
Q2 2022 Aug 04, 2022	BUY	$20.5 - $37.33 $711,350 - $1.3 Million	34,700 Added 1020.59%	38,100 $182,000
Q1 2022 Apr 14, 2022	BUY	$27.64 - $39.32 $55,280 - $78,640	2,000 Added 142.86%	3,400 $12,000
Q4 2021 Jan 18, 2022	SELL	$35.68 - $56.27 $931,248 - $1.47 Million	-26,100 Reduced 94.91%	1,400 $4,000
Q3 2021 Oct 26, 2021	BUY	$28.95 - $55.99 $796,125 - $1.54 Million	27,500 New	27,500 $114,000

199

65.9M

1.68M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.15B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.